PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
Authors
Keywords
-
Journal
BMC CANCER
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-13
DOI
10.1186/s12885-021-08138-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The combination of PIVKA‐II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long‐term oral therapy
- (2020) Alessandro Loglio et al. LIVER INTERNATIONAL
- Prognoses, outcomes, and clinicopathological characteristics of very elderly patients with hepatocellular carcinoma who underwent hepatectomy
- (2020) Shingo Shimada et al. World Journal of Surgical Oncology
- 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights
- (2020) Di-Yang Xie et al. Hepatobiliary Surgery and Nutrition
- Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis
- (2019) Mi Na Kim et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The biological and diagnostic role of miRNA rsquo s in hepatocellular carcinoma
- (2018) Kurt Sartorius Frontiers in Bioscience-Landmark
- Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis
- (2018) Gian Paolo Caviglia et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Progress in non-invasive detection of liver fibrosis
- (2018) Li Chengxi et al. Cancer Biology & Medicine
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma
- (2015) T. Kawai et al. CLINICAL CANCER RESEARCH
- Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma
- (2015) Seung In Seo WORLD JOURNAL OF GASTROENTEROLOGY
- A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis
- (2013) Cheng Xu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP
- (2013) Jong Young Choi WORLD JOURNAL OF GASTROENTEROLOGY
- New Serum Markers of Hepatocellular Carcinoma
- (2012) Ryota Masuzaki et al. SEMINARS IN ONCOLOGY
- Impact of Des-Gamma-Carboxy Prothrombin and Tumor Size on the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation
- (2010) Akinobu Taketomi et al. TRANSPLANTATION
- High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma
- (2009) Masahiro Kobayashi et al. CANCER
- Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden
- (2009) V. T. T. Nguyen et al. JOURNAL OF VIRAL HEPATITIS
- Serum Proteomics and Biomarkers in Hepatocellular Carcinoma and Chronic Liver Disease
- (2008) N. T. Zinkin et al. CLINICAL CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started